Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05051540 · ClinicalTrials.gov registry record · NA

The Effect of Inelastic Compression System on Quality of Life in People With Chronic Venous Insufficiency

A NA study, sponsored by University of Miami.

Completed
Registry status
NA
Development phase
30
Enrollment target

NCT05051540: Completed NA study, sponsored by University of Miami.

NCT05051540 is a NA study that has completed, run by University of Miami. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05051540, a NA study, has completed, sponsored by University of Miami.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

The purpose of this protocol is to measure the effect of the use of an inelastic compression system (ICS) on quality of life (QOL) in patients with chronic venous insufficiency (CVI) who have demonstrated limited or no compliance with prescribed compression stockings or bandage wraps.

Primary Outcome

Chronic Venous Disease Quality of Life Questionnaire (CIVIQ-20) consists of 20 multiple choice questions subdivided into four categories: psychology, pain, physical repercussions and social repercussions. The questionnaire has a total score ranging from 0 to 100 the lower score indicating greater quality of life.

Interventions

  • DEVICE Sigvaris Compreflex Inelastic Compression Wrap

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2021-11-15
Est. Completion 2023-05-17
Phase NA
University of Miami

721 total trials

What the finished NCT05051540 record still lists

NCT05051540 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Sigvaris Compreflex Inelastic Compression Wrap is the first listed.

NCT05051540 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05051540 about?

NCT05051540 is a clinical study titled "The Effect of Inelastic Compression System on Quality of Life in People With Chronic Venous Insufficiency". The purpose of this protocol is to measure the effect of the use of an inelastic compression system (ICS) on quality of life (QOL) in patients with chronic venous insufficiency (CVI) who have demonstrated limited or no compliance with prescribed compression stockings or bandage wraps.

What is the current status of trial NCT05051540?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2021-11-15. Estimated completion is 2023-05-17.

What interventions are being tested in trial NCT05051540?

The interventions under investigation include: Sigvaris Compreflex Inelastic Compression Wrap (DEVICE).

Who is sponsoring clinical trial NCT05051540?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05051540's enrollment target sits among peer trials

30 1593rd of 2000 higher than 299 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05051540, the US trial registry maintained by the National Library of Medicine. NCT05051540 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.